Ulrike Gnad-Vogt
Signal active
Chief Medical Officer
Contact Information
Social
Primary Organization
CureVac
Founded
2000
Employees
251-500
Industry
Biotechnology, Biopharma, Therapeutics
Bio
Ulrike Gnad-Vogt is a board certified medical oncologist and hematologist who worked as attending oncologist at the National Center for tumor diseases (NCT) in Heidelberg before joining CureVac in 2011.
Previously Ulrike was global medical leader for the early clinical and translational development of immunocytokines and a peptide cancer vaccine at Merck Serono in Darmstadt. Ulrike holds a medical degree from the University of Homburg/Saar and received training in internal medicine, hematology and oncology at the University of Mannheim.
Location
Frankfurt, Hessen, Germany, Europe
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Educations
1
Saarland University
Human Medecine
Profile Resume
Ulrike Gnad-Vogt is the Chief Medical Officer at CureVac, based in Europe. With a background in Biotechnology, Ulrike Gnad-Vogt has a rich history of leadership and innovation.Ulrike Gnad-Vogt studied unknown Human Medecine at Saarland University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity